CHUGAI PHARMACEUTICAL CO., LTD. (4519)

Market cap
¥14.42T
P/E ratio
35.2x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
Period EndOperating margin (%) YoY (%)
Dec 31, 202547.6+2.82%
Dec 31, 202446.3+17.17%
Dec 31, 202339.5-6.64%
Dec 31, 202242.3+0.30%
Dec 31, 202142.2+10.24%
Dec 31, 202038.3+24.72%
Dec 31, 201930.7+62.41%
Dec 31, 201818.9+16.59%
Dec 31, 201716.2+15.44%
Dec 31, 201614-3.86%
Dec 31, 201514.6-6.36%
Dec 31, 201415.6
AI Chat